🔎 Trials Near Me

Dachaigh › Aillse nan dubhagan (Carcinoma cealla renach) › Massachusetts › Boston

Sgrùdaidhean clionaigeach Aillse nan dubhagan (Carcinoma cealla renach) ann an Boston, MA

Tha 16 sgrùdaidhean airson Aillse nan dubhagan (Carcinoma cealla renach) a’ lorg phàirtichean aig làraichean ann agus timcheall air Boston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

A’ fastadhÌre 1
  • Research Site, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05536141

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

A’ fastadhÌre 1
  • Exelixis Clinical Site #7, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05176483

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

A’ fastadhÌre 1/2
  • Tufts Medical Center, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06047379

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

A’ fastadhÌre 2
  • Massachusetts General Hospital Cancer Center, Boston
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

A’ fastadhÌre 1/2
  • Brigham and Women's Hospital, Boston
  • Dana Farber/Mass General Brigham Cancer Care, Inc, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07227415

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

A’ fastadhÌre 3
  • Tufts Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06661720

A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

A’ fastadhÌre 2
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT07123090

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

A’ fastadhÌre 1
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06966024

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

A’ fastadhÌre 1
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT07195682

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

A’ fastadhÌre 1/2
  • Massachusetts General Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Iuch 2026 · NCT03972657

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

A’ fastadhÌre 1
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Ògmh 2026 · NCT06026410

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

A’ fastadhÌre 1
  • Beth Israel Deaconess Medical Center /ID# 252009, Boston
  • Dana-Farber Cancer Institute /ID# 249642, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT04777994

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

A’ fastadhÌre 2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT06053658

Drug Screening Using Novel IMD in Renal Cell Carcinoma

A’ fastadhÌre 1
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT05700461

Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC

A’ fastadhÌre 2
  • Beth Israel Deaconess Medical Center, Boston
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Màrt 2026 · NCT07397611

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

A’ fastadhÌre 1/2
  • Massachusetts General Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Samh 2024 · NCT04787042

Sgrùdaidhean Aillse nan dubhagan (Carcinoma cealla renach) ann am bailtean eile

Sgrùdaidhean eile ann an Boston

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.